OSTANU-MAX
₹1,400.00
ALENDRONATE 70 MG TABLET
OSTANU-MAX contains Alendronate, a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women and men at increased risk of fractures. It works by inhibiting bone resorption, which strengthens bones and reduces the likelihood of fractures. This medication is typically used as part of a broader treatment plan that includes calcium and vitamin D supplementation, along with lifestyle modifications. OSTANU-MAX is available in 10x1x4 blister packaging.
HOW DOES IT WORK?
Alendronate targets and binds to bone tissues, specifically inhibiting osteoclasts, the cells responsible for bone breakdown. By inhibiting these cells, Alendronate slows the rate of bone loss, allowing for increased bone density and improved bone strength. This action helps reduce the risk of fractures, particularly in the spine and hip.SIDE EFFECTS
While OSTANU-MAX is generally effective, some patients may experience side effects, including:- Gastrointestinal discomfort (e.g., heartburn, abdominal pain)
- Nausea
- Constipation or diarrhea
- Muscle or joint pain
- Rarely, esophageal irritation or ulceration
ADMINISTRATION OF DOSES
OSTANU-MAX is typically prescribed as one 70 mg tablet taken once weekly. For optimal absorption, it should be taken in the morning with a full glass of water (at least 6–8 oz) on an empty stomach. Patients should avoid eating, drinking, or lying down for at least 30 minutes after taking the medication. Calcium or antacids should be avoided within 30 minutes of dosing to prevent interference with absorption.BENEFITS
- Effectively increases bone mineral density and reduces the risk of fractures in osteoporosis patients (Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13th Edition)
- Helps maintain bone strength in individuals at high risk of bone loss and fractures (Harrison's Principles of Internal Medicine, 20th Edition)
INDICATIONS
OSTANU-MAX is indicated for:- Treatment and prevention of osteoporosis in postmenopausal women and men at risk of fractures (Katzung & Trevor's Basic and Clinical Pharmacology, 14th Edition)
PRECAUTIONS
Patients with esophageal abnormalities, severe kidney disease, or those unable to remain upright for 30 minutes should avoid OSTANU-MAX. This medication is not recommended for use in patients with hypocalcemia (low calcium levels); calcium levels should be corrected before initiating therapy. Pregnant or breastfeeding women should consult their healthcare provider before use. Regular monitoring of bone density and kidney function may be advised during long-term therapy.Related products
-
BETERCAL ( IN DRUG)
₹1,390.00 -
VASTNAC-P
₹368.40 -
FIXACHE G
₹185.00 -
RUTOMOR-D
₹2,290.00
Enquire Us
